Bianca Mostert

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. doi request reprint Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146
    Bianca Mostert
    Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Erasmus MC, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Breast Cancer Res Treat 127:33-41. 2011
  2. doi request reprint Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer
    Bianca Mostert
    Department of Medical Oncology, Erasmus Medical Center Josephine Nefkens Institute and Cancer Genomics Centre, 3015 GE Rotterdam, The Netherlands
    Cancer Treat Rev 35:463-74. 2009
  3. doi request reprint CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes
    Bianca Mostert
    Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Cancer Lett 319:49-55. 2012
  4. doi request reprint Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR
    Anieta M Sieuwerts
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus MC, Room BE 400, Dr Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    Breast Cancer Res Treat 118:455-68. 2009
  5. doi request reprint mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients
    Anieta M Sieuwerts
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Rotterdam, The Netherlands
    Clin Cancer Res 17:3600-18. 2011
  6. doi request reprint KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
    Bianca Mostert
    Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Cancer 133:130-41. 2013
  7. doi request reprint The challenge of gene expression profiling in heterogeneous clinical samples
    F Germán Rodríguez-González
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, The Netherlands
    Methods 59:47-58. 2013
  8. ncbi request reprint Risk of complications during pregnancy in women with congenital aortic stenosis
    Sing Chien Yap
    Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
    Int J Cardiol 126:240-6. 2008

Detail Information

Publications8

  1. doi request reprint Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146
    Bianca Mostert
    Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Erasmus MC, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Breast Cancer Res Treat 127:33-41. 2011
    ..CD146+ CTCs are present in the peripheral blood of breast cancer patients with advanced disease. Combined use of anti-CD146 and anti-EpCAM is likely to improve CTC detection in breast cancer patients...
  2. doi request reprint Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer
    Bianca Mostert
    Department of Medical Oncology, Erasmus Medical Center Josephine Nefkens Institute and Cancer Genomics Centre, 3015 GE Rotterdam, The Netherlands
    Cancer Treat Rev 35:463-74. 2009
    ..We have focused on breast cancer as most clinical studies on CTC detection so far have been done in these patients...
  3. doi request reprint CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes
    Bianca Mostert
    Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Cancer Lett 319:49-55. 2012
    ..Combined staining of CK8/18/19 and CD49f after CD146/EpCAM enrichment is likely to further improve CTC detection in breast cancer...
  4. doi request reprint Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR
    Anieta M Sieuwerts
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus MC, Room BE 400, Dr Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    Breast Cancer Res Treat 118:455-68. 2009
    ..Our method allows molecular characterization specific for as little as one CTC, and can be used to expand the understanding of the biology of metastasis and, potentially, to improve patient management...
  5. doi request reprint mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients
    Anieta M Sieuwerts
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Rotterdam, The Netherlands
    Clin Cancer Res 17:3600-18. 2011
    ..In this study, we determined mRNA and microRNA (miRNA) expression of potentially CTC-specific genes that are considered to be clinically relevant in breast cancer...
  6. doi request reprint KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
    Bianca Mostert
    Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Cancer 133:130-41. 2013
    ..Determination of KRAS and BRAF mutations in CTCs is challenging but feasible. Of the tested methods, nested ASB-PCR, enabling detection of KRAS and BRAF mutations in patients with as little as two CTCs, seems to be superior...
  7. doi request reprint The challenge of gene expression profiling in heterogeneous clinical samples
    F Germán Rodríguez-González
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, The Netherlands
    Methods 59:47-58. 2013
    ....
  8. ncbi request reprint Risk of complications during pregnancy in women with congenital aortic stenosis
    Sing Chien Yap
    Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
    Int J Cardiol 126:240-6. 2008
    ..Data on non-cardiac complications are limited, and this information is crucial for prenatal counselling and perinatal care. The aim of this study was to present the maternal and perinatal outcome of pregnancy in women with congenital AS...